New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same
Oncology January 30,2024
Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

Research reveals why cancers stop responding to kinase-blocking drugs and come back stronger

by New York UniversityStructure of the FGFR kinase showing the locations of the gatekeeper residue in blue, hydrophobic spine in yellow, and ATP in cyan. Most drugs bind to the kinase in the same
Oncology January 30,2024
Researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment

Researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment

by The Spanish National Cancer Research CentreGraphical abstract. Credit:EMBO Molecular Medicine(2023). DOI: 10.15252/emmm.202216715The drug denosumab is currently used to treat osteo
Oncology January 30,2024
Researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment

Researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment

by The Spanish National Cancer Research CentreGraphical abstract. Credit:EMBO Molecular Medicine(2023). DOI: 10.15252/emmm.202216715The drug denosumab is currently used to treat osteo
Oncology January 30,2024
A new nutrition-screening tool for the oncologic population

A new nutrition-screening tool for the oncologic population

byScience China PressVenn plots of three screening tools and malnutrition defined by PG-SGA. Malnutrition was defined as a PG-SGA score of ≥4. The malnutrition risk in MST was defined as an MST
Oncology January 30,2024
A new nutrition-screening tool for the oncologic population

A new nutrition-screening tool for the oncologic population

byScience China PressVenn plots of three screening tools and malnutrition defined by PG-SGA. Malnutrition was defined as a PG-SGA score of ≥4. The malnutrition risk in MST was defined as an MST
Oncology January 30,2024
Quitting smoking early linked with improved survival rates for people diagnosed with lung cancer

Quitting smoking early linked with improved survival rates for people diagnosed with lung cancer

byHarvard T.H. Chan School of Public HealthCredit: Pixabay/CC0 Public DomainQuitting smoking early was associated with higher survival rates following a lung cancer diagnosis, according to a new
Oncology January 30,2024
Quitting smoking early linked with improved survival rates for people diagnosed with lung cancer

Quitting smoking early linked with improved survival rates for people diagnosed with lung cancer

byHarvard T.H. Chan School of Public HealthCredit: Pixabay/CC0 Public DomainQuitting smoking early was associated with higher survival rates following a lung cancer diagnosis, according to a new
Oncology January 30,2024
Novel machine-learning blood test detects cancers with genome-wide mutations in single molecules of cell-free DNA

Novel machine-learning blood test detects cancers with genome-wide mutations in single molecules of cell-free DNA

by Amy Mone,Johns Hopkins UniversitySchematic of overall approach for cancer detection using single-molecule cfDNA sequencing. Credit:Nature Genetics(2023). DOI: 10.1038/s41588-023-0
Oncology January 30,2024
Novel machine-learning blood test detects cancers with genome-wide mutations in single molecules of cell-free DNA

Novel machine-learning blood test detects cancers with genome-wide mutations in single molecules of cell-free DNA

by Amy Mone,Johns Hopkins UniversitySchematic of overall approach for cancer detection using single-molecule cfDNA sequencing. Credit:Nature Genetics(2023). DOI: 10.1038/s41588-023-0
Oncology January 30,2024
Novel prognostic index to predict survival outcomes in gastric cancer patients

Novel prognostic index to predict survival outcomes in gastric cancer patients

by Impact Journals LLCCancer-specific survival curve based on the inflammation-based prognostic index. Abbreviation: ICPI: inflammation based prognostic index. Credit:Oncotarget(2023). DOI
Oncology January 30,2024
Novel prognostic index to predict survival outcomes in gastric cancer patients

Novel prognostic index to predict survival outcomes in gastric cancer patients

by Impact Journals LLCCancer-specific survival curve based on the inflammation-based prognostic index. Abbreviation: ICPI: inflammation based prognostic index. Credit:Oncotarget(2023). DOI
Oncology January 30,2024
Depression linked to deadly inflammation in lung cancer patients

Depression linked to deadly inflammation in lung cancer patients

by Jeff Grabmeier,The Ohio State UniversityKaplan Meier survival curve for NSCLC patients stratified by NLR systemic inflammation, NLR < 5 and NLR ≥ 5 (n = 184), showing worse survival probab
Oncology January 30,2024
Depression linked to deadly inflammation in lung cancer patients

Depression linked to deadly inflammation in lung cancer patients

by Jeff Grabmeier,The Ohio State UniversityKaplan Meier survival curve for NSCLC patients stratified by NLR systemic inflammation, NLR < 5 and NLR ≥ 5 (n = 184), showing worse survival probab
Oncology January 30,2024
How interleukin-6 helps prevent allergic asthma and atopy by suppressing interleukin-2 signaling

How interleukin-6 helps prevent allergic asthma and atopy by suppressing interleukin-2 signaling

by Jeff Hansen,University of Alabama at BirminghamKnowledge of this previously unrecognized mechanism may aid therapy for patients with interleukin-6 signaling mutations and hyper-IgE Syndrome,
inflammatory disease January 29,2024
How interleukin-6 helps prevent allergic asthma and atopy by suppressing interleukin-2 signaling

How interleukin-6 helps prevent allergic asthma and atopy by suppressing interleukin-2 signaling

by Jeff Hansen,University of Alabama at BirminghamKnowledge of this previously unrecognized mechanism may aid therapy for patients with interleukin-6 signaling mutations and hyper-IgE Syndrome,
inflammatory disease January 29,2024
Tool predicts a patient's risk of developing psoriatic arthritis

Tool predicts a patient's risk of developing psoriatic arthritis

by WileyCredit: Unsplash/CC0 Public DomainIn research published inArthritis & Rheumatology, investigators have developed and validated a tool called PRESTO that identifies patients with
Arthritis and Rheumatism January 29,2024
Tool predicts a patient's risk of developing psoriatic arthritis

Tool predicts a patient's risk of developing psoriatic arthritis

by WileyCredit: Unsplash/CC0 Public DomainIn research published inArthritis & Rheumatology, investigators have developed and validated a tool called PRESTO that identifies patients with
Arthritis and Rheumatism January 29,2024
Long COVID not caused by COVID-19 immune inflammatory response, new research finds

Long COVID not caused by COVID-19 immune inflammatory response, new research finds

by University of BristolOngoing symptoms at three months and associations with immune profiles. (A,B) The percentage of patients with mild (N=17), moderate (N=32), and severe (N=14) coronav
inflammatory disease January 29,2024
Long COVID not caused by COVID-19 immune inflammatory response, new research finds

Long COVID not caused by COVID-19 immune inflammatory response, new research finds

by University of BristolOngoing symptoms at three months and associations with immune profiles. (A,B) The percentage of patients with mild (N=17), moderate (N=32), and severe (N=14) coronav
inflammatory disease January 29,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com